-
Mesoblast Cell Therapy Products are Designated U.S. Origin and Not Subject to Tariffs
26 Sep 2025 05:49 GMT
NEW YORK, Sept. 26, 2025 (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, today reiterated that its allogeneic cell therapy products are manufactured from U.S. donors in …
-
Datavault AI (DVLT) Rockets on $150 Million Scilex Cash Infusion: The Deal That’s Got Traders Buzzing
27 Sep 2025 02:24 GMT
… giants, and suddenly, a biotech powerhouse like Scilex drops $ … information securely. Imagine a biotech firm with mountains of … on steroids for chewing through massive data sets. For biotech partners … ? That’s credibility on steroids. It positions DVLT smack …
-
7 FDA Headlines You Missed in September 2025
27 Sep 2025 01:00 GMT
… available for pediatric patients. Krystal Biotech’s beremagene geperpavec-svdt (Vyjuvek … a label update for Krystal Biotech’s beremagene geperpavec-svdt (Vyjuvek … expands access to a non-steroidal JAK1/2 inhibitor option …
-
Serum Metabolic and Gut Microbiome Differences in Age-Associated Fragile X Syndrome (FXS) Pediatric Patients May Benefit Clinical Therapy Development
26 Sep 2025 10:58 GMT
… against the National Center for Biotechnology Information (NCBI)-nt database … revealed significant enrichment in the steroid hormone biosynthetic pathway. Further … outcomes. This indicates that steroid hormone biosynthesis abnormalities may occur …
-
Integrated Single-Cell Analysis Reveals the Heterogeneity of Tumor-Associated Macrophages and Their Implications for Immunotherapy in Colorectal Cancer
26 Sep 2025 10:57 GMT
… , sterol, cholesterol, triglyceride, acylglycerol, and steroid metabolic processes (Figure 3D). The … ordering of single cells. Nat Biotechnol. 2014;32(4):381–386 …
-
Pain Management Drugs Market Size Worth USD 125.68 Billion by 2034 Driven by Aging Population and Rising Chronic Pain Cases
25 Sep 2025 15:23 GMT
… drug delivery, neurolytic procedures, steroid injections, scrambler therapy, muscle relaxers … creating openings for emerging biotech entrants developing non-opioid therapies … toward diversified pharma giants and biotech innovators.
Non-opioid innovation: …
-
Investigating the Mechanism of Jiawei Weijin Decoction in Treating Non-Small Cell Lung Cancer Using Network Pharmacology, Bioinformatics Analysis and Experimental Validation
25 Sep 2025 08:23 GMT
… of Prunella vulgaris L., and steroid saponins, the main ingredient of … ) were purchased from Shulaibao (Wuhan) Biotechnology (Wuhan, Hubei Province, China). Animals … Illumina sequencing platform by Metware Biotechnology (Wuhan, Hubei Province, China). DESeq2 …
-
UniQure stock surges 247% after mid-stage Huntington’s win
25 Sep 2025 11:18 GMT
… resolved with the use of steroids or supportive care.
UniQure eyes … goes to plan, the Dutch biotech anticipates that the drug will … $20m predicted in 2026.
UK biotech back on the map?
While … punching above its weight in biotech innovation. With the right support …
-
Huntington’s Disease Successfully Treated For First Time With Experimental Gene Therapy
24 Sep 2025 22:31 GMT
… . The treatment, developed by the biotechnology company uniQure, involves a one … , though these were resolved with steroids.
The trial involved 29 patients …
-
Huntington’s disease breakthrough: what to know about the gene therapy
24 Sep 2025 21:37 GMT
… therapy, developed by the Dutch biotechnology company uniQure, stops the production … resolved without treatment or with steroids to reduce inflammation.
When will …
About
© 1995-2025